Neurostar Transcranial Magnetic Stimulation (Tms) Therapy Study In Depressed Adolescents
Posted Date: May 15, 2019
- Investigator: Jeffrey Strawn
- Type of Study: Device
The purpose of this study is to get information about using TMS as a treatment for depression in adolescents with Major Depressive Disorder (MDD) who have not had a good response to medication to treat their depression. The NeuroStar has been approved by the U.S. Food and Drug Administration (FDA) f
Criteria:
- Patients 12-21 Years Old - Resistance To Prior Antidepressant Medication - Depression Illness La
Keywords:
Adolescents, Depression, Psychiatry, Transcranial Magneti
For More Information:
Sara Varney
(513) 558-2931
varneysa@ucmail.uc.edu